Pharmadrug Inc. (CSE:PHRX)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Jul 31, 2026, 9:30 AM EST
Pharmadrug Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.05 | 0.02 | 0.08 | 0.41 | 0.01 | 0.96 |
Short-Term Investments | 0.33 | - | - | 0.01 | 0.32 | 0.34 |
Cash & Short-Term Investments | 0.38 | 0.02 | 0.08 | 0.42 | 0.33 | 1.3 |
Cash Growth | 411.43% | -76.15% | -82.26% | 28.49% | -74.58% | -70.59% |
Accounts Receivable | - | - | - | - | - | 0.02 |
Other Receivables | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.06 |
Receivables | 0.02 | 0.01 | 0.02 | 0.02 | 1 | 0.08 |
Inventory | - | - | - | - | - | 0.16 |
Prepaid Expenses | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Restricted Cash | 0.01 | 0.01 | 0.04 | 0.15 | - | - |
Other Current Assets | - | - | - | - | - | 0.05 |
Total Current Assets | 0.41 | 0.04 | 0.15 | 0.6 | 1.34 | 1.59 |
Property, Plant & Equipment | - | - | - | - | - | 0.1 |
Goodwill | - | - | - | - | 6.24 | 10.47 |
Other Intangible Assets | 0.5 | 0.51 | 0.56 | 0.6 | 4.53 | 7.35 |
Total Assets | 0.91 | 0.55 | 0.71 | 1.2 | 12.11 | 19.52 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.33 | 0.34 | 0.6 | 0.45 | 0.53 | 0.25 |
Accrued Expenses | 0.04 | 0.05 | 0.01 | 0.45 | 0.25 | 0.19 |
Short-Term Debt | 0.1 | - | - | - | - | - |
Current Portion of Long-Term Debt | 1.61 | 1.52 | 1.35 | 1.77 | 1.42 | - |
Current Portion of Leases | - | - | - | - | - | 0.04 |
Total Current Liabilities | 2.08 | 1.91 | 1.96 | 2.66 | 2.2 | 0.48 |
Long-Term Debt | - | - | - | - | - | 0.79 |
Long-Term Leases | - | - | - | - | - | 0.04 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.01 | 1.25 |
Other Long-Term Liabilities | 0.29 | 0.29 | - | - | 0.07 | 0.1 |
Total Liabilities | 2.37 | 2.2 | 1.96 | 2.66 | 3.28 | 2.66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 34.4 | 34.01 | 33.99 | 33.21 | 31.22 | 30.61 |
Retained Earnings | -39.68 | -39.49 | -39.11 | -38.3 | -25.12 | -19.4 |
Comprehensive Income & Other | 3.71 | 3.71 | 3.71 | 3.38 | 2.74 | 5.66 |
Total Common Equity | -1.56 | -1.76 | -1.4 | -1.7 | 8.84 | 16.87 |
Minority Interest | 0.1 | 0.11 | 0.16 | 0.24 | - | - |
Shareholders' Equity | -1.46 | -1.65 | -1.24 | -1.47 | 8.84 | 16.87 |
Total Liabilities & Equity | 0.91 | 0.55 | 0.71 | 1.2 | 12.11 | 19.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.71 | 1.52 | 1.35 | 1.77 | 1.42 | 0.87 |
Net Cash (Debt) | -1.32 | -1.5 | -1.27 | -1.34 | -1.09 | 0.43 |
Net Cash Growth | - | - | - | - | - | -86.91% |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.01 |
Filing Date Shares Outstanding | 134.21 | 134.21 | 108.2 | 104.69 | 50.8 | 49.48 |
Total Common Shares Outstanding | 134.21 | 108.23 | 107.73 | 88.17 | 50.8 | 48.69 |
Working Capital | -1.67 | -1.88 | -1.81 | -2.07 | -0.86 | 1.11 |
Book Value Per Share | -0.01 | -0.02 | -0.01 | -0.02 | 0.17 | 0.35 |
Tangible Book Value | -2.06 | -2.28 | -1.97 | -2.31 | -1.94 | -0.96 |
Tangible Book Value Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.02 |
Machinery | - | - | - | - | - | 0.05 |